Total marrow and lymphoid irradiation in combination with cyclophosphamide and etoposide before haematopoietic cell transplantation for relapsed or refractory acute leukaemia: a single-centre, open-label, phase 2 trial.

Stein A, Wang Y, Malki MMA, Aldoss I, Ali H, Aribi A, Artz A, Ball B, Dandapani S, Farol L, Han C, Liu A, Pullarkat V, Radany E, Sahebi F, Sanchez JF, Sandhu K, Salhotra A, Smith E, Spielberger R, Hui S, Marcucci G, Nakamura R, Forman SJ, Palmer J, Wong J.

Open source

DOI: 10.1016/s2352-3026(26)00014-1
Published: 2026-05-18
Container: Lancet Haematol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3026-26-00014-1,
  title = {Total marrow and lymphoid irradiation in combination with cyclophosphamide and etoposide before haematopoietic cell transplantation for relapsed or refractory acute leukaemia: a single-centre, open-label, phase 2 trial.},
  author = {Stein A and  Wang Y and  Malki MMA and  Aldoss I and  Ali H and  Aribi A and  Artz A and  Ball B and  Dandapani S and  Farol L and  Han C and  Liu A and  Pullarkat V and  Radany E and  Sahebi F and  Sanchez JF and  Sandhu K and  Salhotra A and  Smith E and  Spielberger R and  Hui S and  Marcucci G and  Nakamura R and  Forman SJ and  Palmer J and  Wong J.},
  year = {2026},
  journal = {Lancet Haematol},
  doi = {10.1016/s2352-3026(26)00014-1},
  url = {https://doi.org/10.1016/s2352-3026(26)00014-1}
}

RIS

TY  - JOUR
TI  - Total marrow and lymphoid irradiation in combination with cyclophosphamide and etoposide before haematopoietic cell transplantation for relapsed or refractory acute leukaemia: a single-centre, open-label, phase 2 trial.
AU  - Stein A
AU  -  Wang Y
AU  -  Malki MMA
AU  -  Aldoss I
AU  -  Ali H
AU  -  Aribi A
AU  -  Artz A
AU  -  Ball B
AU  -  Dandapani S
AU  -  Farol L
AU  -  Han C
AU  -  Liu A
AU  -  Pullarkat V
AU  -  Radany E
AU  -  Sahebi F
AU  -  Sanchez JF
AU  -  Sandhu K
AU  -  Salhotra A
AU  -  Smith E
AU  -  Spielberger R
AU  -  Hui S
AU  -  Marcucci G
AU  -  Nakamura R
AU  -  Forman SJ
AU  -  Palmer J
AU  -  Wong J.
PY  - 2026
JO  - Lancet Haematol
DO  - 10.1016/s2352-3026(26)00014-1
UR  - https://doi.org/10.1016/s2352-3026(26)00014-1
ER  -

APA

A, S., Y, W., MMA, M., I, A., H, A., A, A., A, A., B, B., S, D., L, F., C, H., A, L., V, P., E, R., F, S., JF, S., K, S., A, S., E, S., R, S., S, H., G, M., R, N., SJ, F., J, P., & J., W. (2026). Total marrow and lymphoid irradiation in combination with cyclophosphamide and etoposide before haematopoietic cell transplantation for relapsed or refractory acute leukaemia: a single-centre, open-label, phase 2 trial.. Lancet Haematol. https://doi.org/10.1016/s2352-3026(26)00014-1

Source records

europe-pmc · retrieved 2026-09-26T20:26:48.966Z